An analysis of high glucose and glucosamine-induced gene expression and oxidative stress in renal mesangial cells

Archives of Physiology and Biochemistry

Volumn 112, Issue 4-5, 2006, Pages 189-218

  Cheng, Davis W ^a   Jiang, Yan ^a   Shalev, Anath ^b   Kowluru, Renu ^a   Crook, Errol D ^c   Singh, Lalit P ^a  

^a WAYNE STATE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

^c UNIVERSITY OF SOUTH ALABAMA COLLEGE OF MEDICINE   (United States)

Author keywords

Apoptosis; Hexosamines; Microarray analysis; Oxidative stress; TXNIP

Indexed keywords

GLUCOSAMINE; GLUCOSE; MESSENGER RNA; PROTEIN; THIOREDOXIN INTERACTING PROTEIN; UNCLASSIFIED DRUG;

ANALYSIS; ANIMAL CELL; APOPTOSIS; ARTICLE; CELL METABOLISM; CONTROLLED STUDY; DOWN REGULATION; ENDOPLASMIC RETICULUM STRESS; EXTRACELLULAR MATRIX; GENE EXPRESSION; GENE OVEREXPRESSION; MESANGIUM CELL; MICROARRAY ANALYSIS; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATIVE STRESS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UNINDEXED SEQUENCE; UPREGULATION;

ANIMALS; APOPTOSIS; CARRIER PROTEINS; CELL LINE; DIABETIC NEPHROPATHIES; GENE EXPRESSION REGULATION; GLOMERULAR MESANGIUM; GLUCOSAMINE; GLUCOSE; GLUCOSE-6-PHOSPHATE; HEXOSAMINES; MESANGIAL CELLS; MICE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; RNA, MESSENGER; SIGNAL TRANSDUCTION; THIOREDOXINS; TRANSCRIPTION, GENETIC;

MURINAE;

EID: 33845890016     PISSN: 13813455     EISSN: 17444160     Source Type: Journal    
DOI: 10.1080/13813450601093518     Document Type: Article

References (49)

1. Akimoto Y, Hart GW, Hirano H, Kawakami H. 2005. O-GlcNAc modification of nucleocytoplasmic proteins and diabetes. Med Mol Morphol 38(2):84-91.
2. Andreozzi F, D'Alessandris C, Federici M, Laratta E, Del Guerra S, Del Prato S, Marchetti P, Lauro R, Perticone F, Sesti G. 2004. Activation of the hexosamine pathway leads to phosphorylation of insulin receptor substrate-1 on Ser307 and Ser612 and impairs the phosphatidylinositol 3-kinase/Art/mammalian target of rapamycin insulin biosynthetic pathway in RIN pancreatic β-cells. Endocrinol 145:2845-57.
3. Brownlee M. 2005. The pathobiology of Diabetic complications. A unifying mechanism. Diabetes 54:1615-25.
4. Buse MA. 2005. Hexosamines, insulin resistance, and the complications of diabetes: current status. Am J Physiol Endocrinol Metab 290:E1-8.
5. Choudhury GG. 2004. A linear signal transduction pathway involving phosphatidylinositol 3-kinase, protein kinase C epsilon, and MAPK in mesangial cells regulates interferon-gamma-induced STAT1 alpha transcriptional activation. J Biol Chem 279:27399-409.
6. Comer F-I, Hart GW. 2000. O-Glycosylation of nuclear and cytosolic proteins. Dynamic interplay between O-GlcNAc and O-phosphate. J Biol Chem 22:29179-82.
7. Daniels MC, Kansal P, Smith TM, Paterson AJ, Kudlow JE, McClain DA. 1993. Glucose regulation of transforming growth factor alpha expression is mediated by products of the hexosamine biosynthesis pathway. Molecular Endocrinol 7:1041-8.
8. Daniels MC, McClain DA, Crook ED. 2000. Transcriptional regulation of TGF-β1 by glucose: investigation into the role of the hexosamine biosynthesis pathway. Am J Med Sci 319:138-42.
9. Du XL, Edelstein D, Rossetti L, Fantus IG, Goldberg H, Ziyadeh F, Wu J, Brownlee M. 2000. Hyperglycemia-induced mitochondrial superoxide overproduction activates the hexosamine pathway and induces plasminogen activator inhibitor-1 expression by increasing Sp1 glycosylation. Proc Natl Aca Sci USA 97:12222-6.
10. Elliot NA, Volkert MR. 2004. Stress induction and mitochondrial localization of Oxr1 proteins in yeast and humans. Mol Cell Biol 24:3180-7.
11. Follmann H, Haberlein I. 1995. Thioredoxins: universal, yet specific thiol-disulfide redox cofactors. Biofactors 5:147-56.
12. Fischer JW, Tschope C, Reinecke A, Giachelli CM, Unger T. 1998. Upregulation of osteopontin expression in renal cortex of streptozotocin-induced diabetic rats is mediated by bradykinin. Diabetes 47:1512-8.
13. Gabriely I, Yang XM, Cases JA, Ma XH, Rossetti L, Barzilai N. 2001. Hyperglycemia modulates angiotensinogen gene expression. Am J Physiol Regul Integr Comp Physiol 281:R795-802.
14. Gething MJ, Sambrook J. 1992. Protein folding in the cell. Nature 355:33-45.
15. Gronbaek H, Volmers P, Bjorn S, Osterby R, Orskov H, Flyvbjerg A. 1997. Effect of GH/IGF-I deficiency on long-term renal changes and urinary albumin excretion in diabetic dwarf rats. Am J Physiol Endocrinol Metabol 272:E918-24.
16. Herbert LF Jr, Zhou J, Daniel MC, Crook ED, Turner RL, Simmons ST, Neidigh JL, Zhu J, Baron AD, McClain DA. 1996. Overexpression of glutamine:fructose-6-phosphate amidotransferase in transgenic mice leads to insulin resistance. J Clin Invest 98:930-6.
17. Hsieh TJ, Fustier P, Zhang SL, Filep JG, Tang SS, Ingelfinger JR, Fantus IG, Hamet P, Chan JS. 2003. High glucose stimulates angiotensinogen gene expression and cell hypertrophy via activation of the hexosamine biosynthesis pathway in rat kidney proximal tubular cells. Endocrinol 144:4338-49.
18. Jiang Y, Cheng DW, Crook ED, Singh LP. 2005. Transforming growth factor-beta1 regulation of laminin gamma1 and fibronectin expression and survival of mouse mesangial cells. Mol Cell Biochem 278:165-75.
19. Kim Y, Zhu J, Zierath J, Shen H, Baron A, Kahn BB. 1999. Glucosamine infusion in rats rapidly impairs insulin stimulation of phosphoinositide 3-kinase but does not alter activation of Akt/protein kinase B in skeletal muscle. Diabetes 48:310-20.
20. Kobayashi T, Uehara S, Ikeda T, Itadani H, Kotani H. 2003. Vitamin D3 up-regulated protein-1 regulates collagen expression in mesangial cells. Kidney Int 64:1632-42.
21. Kolm-Litty V, Sauer U, Nerlich A, Lehmann R, Schleicher ED. 1998. High glucose-induced transforming growth factor β1 production is mediated by the hexosamine pathway in porcine glomerular mesangial cells. J Clin Invest 101:160-9.
22. Lee KN, Kang HS, Jeon JH, Kim EM, Yoon SR, Song H, Lyu CY, Piao ZH, Kim SU, Han YH, Song SS, Lee YH, Song KS, Kim YM, Yu DY, Choi I. 2005. VDUP1 is required for the development of natural killer cells. Immunity 22:195-208.
23. -Δ Δ ct method. Methods 25:402-8.
24. MacKay K, Striker L, Stauffer JW, Doi T, Agodoa LY, Striker GE. 1989. Transforming growth factor-beta. Murine glomerular receptors and responses of isolated glomerular cells. J Clin Invest 83:160-7.
25. Marshall S, Bacote V, Traxeler RR. 1991. Discovery of a metabolic pathway mediating glucose-induced desensitization of the glucose transport system: role of hexosamine biosynthesis in the induction of insulin resistance. J Biol Chem 266:4706-12.
26. Milewski S. 2002. Glucosamine-6-phosphate synthase - the multifacets enzyme. Biochem Biophys Acta 1597:173-92.
27. Minn AH, Hafele C, Shalev A. 2005a. Thioredoxin-interacting protein is stimulated by glucose through a carbohydrate response element and induces β-cell apoptosis. Endocrinol 146:2397-405.
28. Minn AH, Pise-Masison CA, Radonovich M, Brady JN, Wang P, Kendziorski C, Shalev A. 2005b. Gene expression profiling in INS-1 cells overexpressing thioredoxin-interacting protein. Biochem Biophys Res Commun 336:770-8.
29. Mirkovitch J, Decker T, Darnell Jr JE. 1992. Interferon induction of gene transcription analyzed by in vivo footprinting. Mol Cell Biol 12:1-9.
30. Mogyorosi A, Ziyadeh FN. 1996. Update on pathogenesis, markers and management of diabetic nephropathy. Curr Opin Nephrol Hyperten 5:243-53.
31. Morrison J, Knoll K, Hessner MJ, Liang M. 2004. Effect of high glucose on gene expression in mesangial cells: upregulation of the thiol pathway is an adaptation response. Physiol Genomics 17:271-82.
32. Murphy M, Godson C, Cannon S, Kato S, Mackenzie HS, Martin F, Brady HR. 1999. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J Biol Chem 274:5830-4.
33. Nishiyama A, Matsui M, Iwata S, Hirota K, Masutani H, Nakamura H, Takagi Y, Sono H, Gon Y, Yodoi J. 1999. Identification of thioredoxin-binding protein-2/vitamin D(3) up-regulated protein 1 as a negative regulator of thioredoxin function and expression. J Biol Chem 274:21645-50.
34. Pang Y, Bounelis P, Chatham JC, Marchase RB. 2004. Hexosamine pathway is responsible for inhibition by diabetes of phenylephrine-induced inotrophy. Diabetes 53:1074-81.
35. Rossetti L, Hawkins M, Chen W, Gindi J, Barzilai N. 1995. In vivo glucosamine infusion induces insulin resistance in normoglycemic but not hyperglycemic conscious rats. J Clin Invest 96:132-40.
36. Sakatsume M, Narita I, Yamazaki H, Saito A, Nakagawa Y, Kuriyama H, Kuwano R, Gejyo F, Arakawa M. 2000. Down-regulation of interferon-gamma signaling by gene transfer Stat1 mutant in mesangial cells. Kidney Int 57:455-63.
37. Schulze PC, Yoshioka J, Takahashi T, He Z, King GL, Lee RT. 2004. Hyperglycemia promotes oxidative stress through inhibition of thioredoxin function by thioredoxin-interacting protein. J Biol Chem 279:30369-74.
38. Sen CK. 2000. Cellular thiols and redox-regulated signal transduction. Curr Top Cell Regul 36:1-30.
39. Sharma K, Ziyadeh FN. 1995. Hyperglycemia and diabetic kidney disease. The case for transforming growth factor-beta as a key mediator. Diabetes 44:1139-46.
40. Singh LP, Andy JC, Anyamale V, Greene K, Alexander M, Crook ED. 2001a. The hexosamine biosynthesis pathway-mediated fibronectin synthesis in mesangial cells is associated with increases in CREB phosphorylation and nuclear CRE binding. The involvement of protein kinase A and C. Diabetes 50:2355-62.
41. Singh LP, Crook ED. 2000. Hexosamine regulation of glucose-mediated laminin synthesis in mesangial cells involves protein kinase A and C. Am J Physiol Renal Physiol 279:F646-54.
42. Singh LP, Cheng DW, Kowluru R, Levi E, Jiang Y. Hexosamine induction of oxidative stress, hypertrophy and laminin expression in renal mesangial cells: effect of anti-oxidant α-lipoic acid. Cell Biochem Func (in press).
43. Singh LP, Gennerette D, Simmons S, Crook ED. 2001b. Glucose-induced insulin resistance of phosphatidylinositol 3'OH kinase and AKT/PKB is mediated by the hexosamine biosynthetic pathway. J Diab & Its Compl 15:88-96.
44. Singh LP, Green K, Alexander M, Bassly S, Crook ED. 2004. Hexosamines and TGF-beta1 use similar signaling pathways to mediate matrix protein synthesis in mesangial cells. Am J Physiol Renal Physiol 286:F409-16.
45. Tanaka T, Nakamura H, Nishiyama A, Hosoi F, Masutani H, Wada H, Yodoi J. 2001. Redox regulation by thioredoxin superfamily: protection against oxidative stress and aging. Free Radic Res 33:851-5.
46. Wang X, Shaw S, Amiri F, Eaton DC, Marrero MB. 2002. Inhibition of Jak/STAT signaling pathway prevents the high glucose-induced increase in TGF-beta and fibronectin synthesis in mesangial cells. Diabetes 51:3505-9.
47. Weigert C, Brodbeck K, Sawadogo M, Haring HU, Schleicher ED. 2004. Upstream stimulatory factor (USF) proteins induce human TGF-beta1 gene activation via the glucose-response element-1013/-1002 in mesangial cells: upregulation of USF activity by the hexosamine biosynthetic pathway. J Biol Chem 279:15908-15.
48. Zhu Y, Casado M, Vaulont S, Sharma K. 2005. Role of upstream stimulatory factors in regulation of renal transforming growth factor-beta1. Diabetes 54:1976-84.
49. Ziyadeh FN. 1995. Mediators of hyperglycemia and the pathogenesis of matrix accumulation in diabetic renal disease. Mine Electrol Metab 21:292-302.